Skip to main content
Structure Therapeutics Inc. logo

Structure Therapeutics Inc. — Investor Relations & Filings

Ticker · GPCR ISIN · US86366E1064 US Manufacturing
Filings indexed 223 across all filing types
Latest filing 2026-05-07 Prospectus
Country US United States of America
Listing US GPCR

About Structure Therapeutics Inc.

https://structuretx.com/

Structure Therapeutics Inc. is a clinical-stage biopharmaceutical company that utilizes a proprietary structure-based drug design platform to discover and develop novel oral small molecule therapeutics. The company focuses on creating more accessible treatments for a range of chronic diseases by targeting G protein-coupled receptors (GPCRs), a well-validated class of drug targets. Its clinical pipeline includes drug candidates for cardiometabolic conditions, such as obesity and type 2 diabetes, as well as pulmonary diseases.

Recent filings

Filing Released Lang Actions
424B5 - Structure Therapeutics Inc. (0001888886) (Filer)
Prospectus
2026-05-07 English
ARS - Structure Therapeutics Inc. (0001888886) (Filer)
Annual Report
2026-04-23 English
8-K - Structure Therapeutics Inc. (0001888886) (Filer)
Regulatory Filings
2026-04-15 English
10-K - STRUCTURE THERAPEUTICS INC. (0001888886) (Filer)
Annual Report FY 2025
2026-02-26 English
8-K - STRUCTURE THERAPEUTICS INC. (0001888886) (Filer)
Regulatory Filings
2026-02-26 English
SCHEDULE 13G/A Filing
Major Shareholding Notification
2026-02-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.